715.2000 4.90 (0.69%)
NSE Jul 15, 2025 15:31 PM
Volume: 366.0K
 

Axis Direct
KIMS has planned to add incremental bed capacity by 50% over the next 36-40 months. Furthermore, it has the highest return ratios with RoIC of 32% in the industry exhibiting low Capex per bed (Rs 36 Lc/bed) and high EBIT margins (22.7%).
Prabhudas Lilladhar released a Buy report for Krishna Institute of Medical Sciences Ltd. with a price target of 725.0 on 30 Jun, 2025.
More from Krishna Institute of Medical Sciences Ltd.
Recommended